Skip to main content
Clinical Trials/NCT01983319
NCT01983319
Completed
Not Applicable

Transcranial Direct Current Stimulation Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery

University of Aarhus1 site in 1 country64 target enrollmentJanuary 2014
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
University of Aarhus
Enrollment
64
Locations
1
Primary Endpoint
Change in Upper Limb function
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study is to determine whether noninvasive brain stimulation in form of active transcranial direct current stimulation (tDCS) combined with constraint induced movement therapy (CIMT) offers an additional benefit as compared with sham tDCS combined with CIMT in patients with stroke. Furthermore the purpose is to highlight changes in GABA activity more than 3 months after stroke and its importance for effect of tDCS and CIMT combined with tDCS.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Krystian Figlewski

MD

University of Aarhus

Eligibility Criteria

Inclusion Criteria

  • stroke onset \>3 months prior to study enrollment
  • subject has at least 10 degrees mobility over wrist, thumb and fingers on the affected side
  • subject can move, stand up and stand firmly with constrained healthy hand
  • subject can perform training 6 hours daily in 2 weeks
  • subject is able to understand instructions and be able to cooperate

Exclusion Criteria

  • pregnancy
  • contraindications to MRI of brain
  • epilepsy, major psychiatric disease
  • excessive pain that prevents training
  • history of other diseases resulting decreased mobility of affected upper limb

Outcomes

Primary Outcomes

Change in Upper Limb function

Time Frame: Baseline and posttest (an average of 2 weeks from baseline)

The motor function assessment will be done with: Wolf Motor Function Test

Secondary Outcomes

  • GABA (gamma-aminobutyric acid) activity(Baseline)

Study Sites (1)

Loading locations...

Similar Trials